Woebot Health
535 Mission Street, San Francisco, California, 94105, United States
Overview
Woebot Health offers an AI-driven behavioral health platform centered on a relational agent called Woebot that delivers continuous, purely digital therapeutic experiences. The product combines sophisticated AI with decades of clinically proven therapeutic research to provide empathic, personalized apps for individuals and business customers. The company emphasizes clinical evidence and partners with employers, health systems and plans to scale access. Woebot plans to accelerate further development of its platform and products following new investment and expanded collaboration opportunities. Financially, the firm previously closed a $90 million Series B in 2021 and has raised $123.5 million in total to date. The company is based in San Francisco. Woebot Health builds an AI-powered relational platform centered on its proprietary relational agent, Woebot, which creates human-like therapeutic interactions. The company translates evidence-based therapeutic approaches into scalable, responsive software intended to integrate within health ecosystems. Woebot Health is advancing digital therapeutic candidates, including WB001 which received FDA Breakthrough Device designation. The firm published a large-scale study showing Woebot can establish a therapeutic bond with users, supporting its clinical and scalability claims. Founded in 2017, the company plans to use new funding to accelerate platform and technology development, advance lead digital therapeutics, and expand its team and go-to-market efforts to meet surging global demand for mental health care. Woebot Labs builds an AI-powered, research-backed chatbot that delivers mental health support. The product is supported by a controlled research trial that showed reductions in depression and anxiety symptoms after two weeks. It is available on Facebook Messenger and the iTunes App Store, with an Android release planned later this month. Led by CEO and founder Dr. Alison Darcy, the company focuses on expanding access to mental health care. The company raised funding to further develop the AI technology powering Woebot and to expand delivery of its services worldwide.
- Total raised
- $108M
- Funding rounds
- 3
- Latest round
- Equity
- Latest activity
- Mar 2022
Industries
- Artificial Intelligence (AI)
- Health Care
- Mental Health
- mHealth
- Software
- Therapeutics
Recent funding
Equity
Mar 2022
$10M
Series B
Jul 2021
$90M
Series A
Mar 2018
$8M